Skip to main content
Full access
Articles
Published Online: 29 July 2022

Reminder-Focused Positive Psychiatry: Suicide Prevention Among Youths With Comorbid Posttraumatic Stress Disorder and Suicidality

Abstract

Objective:

This study aimed to investigate the effect of brief reminder-focused positive psychiatry and suicide prevention (RFPP-S) on suicidal ideation, posttraumatic stress disorder (PTSD) symptoms, and clinical outcomes among youths with PTSD treated in psychiatric emergency rooms.

Methods:

This study included youths with PTSD and suicidality who received either RFPP-S (N=50) or treatment as usual (N=150). The Columbia Suicide Severity Rating Scale (C-SSRS), Clinician-Administered PTSD Scale for children and adolescents, University of California, Los Angeles Trauma Reminder Inventory, Patient Health Questionnaire–9, Positive Emotion, Engagement, Relationships, Meaning, and Accomplishment Scale, and positive psychiatry test batteries were administered at baseline, on day 2, and 1 week and 1 month after discharge.

Results:

On day 2, the RFPP-S group showed a greater reduction in PTSD symptoms (55%) and reactivity to trauma and loss reminders (80%) compared with the control group (10% for both) (p=0.001). A significantly greater reduction in C-SSRS score for RFPP-S (80%), compared with treatment as usual (15%), was noted (p=0.001), and RFPP-S showed more rapid stabilization (mean±SD=2.0±0.5 days) and enhanced postdischarge follow-up (100%) compared with treatment as usual (5.0±2.0 days and 50%, respectively) (p<0.05). RFPP-S, but not treatment as usual, was associated with significant increases in well-being, flexible thinking, and coping skills (p<0.05). Hospital readmission due to suicidality 1 month after discharge was 0% for the RFPP-S group and 20% for the control group.

Conclusions:

RFPP-S was associated with reduced PTSD symptoms, enhanced coping skills while experiencing trauma reminders, adoption of safety skills, rapid stabilization of acute crises of PTSD with suicidality, adherence to post–emergency room visits and treatment, and favorable clinical outcomes.

Formats available

You can view the full content in the following formats:

Information & Authors

Information

Published In

Go to American Journal of Psychotherapy
Go to American Journal of Psychotherapy
American Journal of Psychotherapy
Pages: 114 - 121
PubMed: 35903914

History

Received: 29 December 2020
Revision received: 18 July 2021
Revision received: 29 December 2021
Accepted: 18 January 2022
Published online: 29 July 2022
Published in print: September 01, 2022

Keywords

  1. Posttraumatic Stress Disorder see Trauma- and Stressor-Related Disorders
  2. Reminder-focused positive psychiatry
  3. suicide prevention
  4. emergency room
  5. adolescent
  6. brief emergency room youth intervention

Authors

Details

Naser Ahmadi, M.D., Ph.D. [email protected]
David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles (all authors); Olive View–UCLA Medical Center, Sylmar, California (Ahmadi, Kopelowicz).
Robert Pynoos, M.D., M.P.H.
David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles (all authors); Olive View–UCLA Medical Center, Sylmar, California (Ahmadi, Kopelowicz).
Andrew Leuchter, M.D.
David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles (all authors); Olive View–UCLA Medical Center, Sylmar, California (Ahmadi, Kopelowicz).
Alex Kopelowicz, M.D.
David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles (all authors); Olive View–UCLA Medical Center, Sylmar, California (Ahmadi, Kopelowicz).

Notes

Send correspondence to Dr. Ahmadi ([email protected]).

Funding Information

Dr. Leuchter has received research support from the National Institutes of Health and the U.S. Department of Defense.Dr. Pynoos is the chief medical officer of Behavioral Health Innovations. Dr. Leuchter has also received research support from Neuronetics, CHDI Foundation, and NeuroSigma and has served as a consultant to NeoSync, Ionis Pharmaceuticals, and ElMindA. He is chief scientific officer of Brain Biomarker Analytics (BBA) and has equity interest in BBA. The other authors report no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Full Text

View Full Text

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - APT - American Journal of Psychotherapy

PPV Articles - APT - American Journal of Psychotherapy

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share